Novartis Malaria Innovation and Access Journey [Video]

More than 20 years ago today, Novartis signed an agreement with World Health Organization to make its antimalarial available without profit to the public sector in malaria-endemic countries. Although the agreement expired in 2011, Novartis continues to provide treatments on the same terms as before. Since then more than 1 billion antimalarials have been delivered in 70+ countries in collaboration with our partners. Track our journey toward malaria elimination.

Learn more: https://go.novartis.social/3UcmlLX